Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free UPHL Stock Alerts

UpHealth (UPHL) Competitors

$0.0003 0.00 (0.00%)
As of 07/29/2026 10:08 AM Eastern
Compare

UPHL vs. BTTX, ACONW, DHACW, LFMDP, and PIIIW

Should you buy UpHealth stock or one of its competitors? MarketBeat compares UpHealth with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with UpHealth include Better Therapeutics (BTTX), Aclarion (ACONW), Digital Health Acquisition (DHACW), LifeMD (LFMDP), and P3 Health Partners (PIIIW). These companies are all part of the "healthcare" industry.

How does UpHealth compare to Better Therapeutics?

Better Therapeutics (NASDAQ:BTTX) and UpHealth (NYSE:UPHL) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation.

Better Therapeutics has higher earnings, but lower revenue than UpHealth. Better Therapeutics is trading at a lower price-to-earnings ratio than UpHealth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Better TherapeuticsN/AN/A-$39.76M-$0.39N/A
UpHealth$130M0.00-$56.42M$1.980.00

34.0% of Better Therapeutics shares are held by institutional investors. Comparatively, 56.1% of UpHealth shares are held by institutional investors. 51.4% of Better Therapeutics shares are held by company insiders. Comparatively, 34.2% of UpHealth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Better TherapeuticsN/A N/A N/A
UpHealth N/A N/A N/A

In the previous week, Better Therapeutics' average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score.

Company Overall Sentiment
Better Therapeutics Neutral
UpHealth Neutral

Better Therapeutics has a beta of 0.87, suggesting that its stock price is 13% less volatile than the broader market. Comparatively, UpHealth has a beta of 0.5, suggesting that its stock price is 50% less volatile than the broader market.

Summary

UpHealth beats Better Therapeutics on 4 of the 7 factors compared between the two stocks.

How does UpHealth compare to Aclarion?

Aclarion (NASDAQ:ACONW) and UpHealth (NYSE:UPHL) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability, media sentiment and earnings.

Company Net Margins Return on Equity Return on Assets
AclarionN/A N/A N/A
UpHealth N/A N/A N/A

In the previous week, Aclarion had 2 more articles in the media than UpHealth. MarketBeat recorded 2 mentions for Aclarion and 0 mentions for UpHealth. Aclarion's average media sentiment score of 1.44 beat UpHealth's score of 0.00 indicating that Aclarion is being referred to more favorably in the media.

Company Overall Sentiment
Aclarion Positive
UpHealth Neutral

56.1% of UpHealth shares are owned by institutional investors. 34.2% of UpHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Aclarion has higher earnings, but lower revenue than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aclarion$77.88KN/AN/AN/AN/A
UpHealth$130M0.00-$56.42M$1.980.00

Summary

UpHealth beats Aclarion on 3 of the 5 factors compared between the two stocks.

How does UpHealth compare to Digital Health Acquisition?

UpHealth (NYSE:UPHL) and Digital Health Acquisition (NASDAQ:DHACW) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations and media sentiment.

In the previous week, UpHealth's average media sentiment score of 0.00 equaled Digital Health Acquisition'saverage media sentiment score.

Company Overall Sentiment
UpHealth Neutral
Digital Health Acquisition Neutral

56.1% of UpHealth shares are owned by institutional investors. 34.2% of UpHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
UpHealthN/A N/A N/A
Digital Health Acquisition N/A N/A N/A

Digital Health Acquisition has lower revenue, but higher earnings than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UpHealth$130M0.00-$56.42M$1.980.00
Digital Health AcquisitionN/AN/AN/AN/AN/A

Summary

UpHealth beats Digital Health Acquisition on 3 of the 3 factors compared between the two stocks.

How does UpHealth compare to LifeMD?

LifeMD (NASDAQ:LFMDP) and UpHealth (NYSE:UPHL) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, risk, profitability, media sentiment and valuation.

In the previous week, LifeMD had 2 more articles in the media than UpHealth. MarketBeat recorded 2 mentions for LifeMD and 0 mentions for UpHealth. LifeMD's average media sentiment score of 1.43 beat UpHealth's score of 0.00 indicating that LifeMD is being referred to more favorably in the media.

Company Overall Sentiment
LifeMD Positive
UpHealth Neutral

56.1% of UpHealth shares are held by institutional investors. 34.2% of UpHealth shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

LifeMD has higher revenue and earnings than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeMD$193.33MN/AN/AN/AN/A
UpHealth$130M0.00-$56.42M$1.980.00

Company Net Margins Return on Equity Return on Assets
LifeMDN/A N/A N/A
UpHealth N/A N/A N/A

Summary

LifeMD beats UpHealth on 3 of the 5 factors compared between the two stocks.

How does UpHealth compare to P3 Health Partners?

P3 Health Partners (NASDAQ:PIIIW) and UpHealth (NYSE:UPHL) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk.

P3 Health Partners has higher revenue and earnings than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
P3 Health Partners$1.47BN/AN/AN/AN/A
UpHealth$130M0.00-$56.42M$1.980.00

Company Net Margins Return on Equity Return on Assets
P3 Health PartnersN/A N/A N/A
UpHealth N/A N/A N/A

In the previous week, P3 Health Partners had 2 more articles in the media than UpHealth. MarketBeat recorded 2 mentions for P3 Health Partners and 0 mentions for UpHealth. P3 Health Partners' average media sentiment score of 1.43 beat UpHealth's score of 0.00 indicating that P3 Health Partners is being referred to more favorably in the media.

Company Overall Sentiment
P3 Health Partners Positive
UpHealth Neutral

56.1% of UpHealth shares are owned by institutional investors. 34.2% of UpHealth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

P3 Health Partners beats UpHealth on 3 of the 5 factors compared between the two stocks.

Get UpHealth News Delivered to You Automatically

Sign up to receive the latest news and ratings for UPHL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UPHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UPHL vs. The Competition

Export
MetricUpHealthHealth services IndustryMedical SectorNYSE Exchange
Market Cap$6K$923.67K$7.04B$23.53B
Dividend YieldN/AN/A2.65%4.19%
P/E Ratio0.00N/A27.6930.73
Price / Sales0.000.00488.1981.94
Price / CashN/AN/A51.7431.18
Price / Book0.000.0010.044.66
Net Income-$56.42M-$48.09M$3.60B$1.07B
7 Day PerformanceN/AN/A0.66%0.55%
1 Month PerformanceN/AN/A-3.29%1.58%
1 Year PerformanceN/AN/A24.47%17.66%

UpHealth Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UPHL
UpHealth
N/A$0.00
flat		N/A+50.0%$6K$130MN/A1,750
BTTX
Better Therapeutics
N/A$0.00
flat		N/A+0.0%$4KN/AN/A40
ACONW
Aclarion
N/A$0.02
-3.6%		N/A-16.2%$0.00$77.88KN/A7
DHACW
Digital Health Acquisition
N/A$0.02
flat		N/A-55.6%$0.00N/AN/AN/A
LFMDP
LifeMD
N/A$23.46
+0.5%		N/A-2.3%$0.00$193.33MN/A230

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:UPHL) was last updated on 7/31/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
“The unseen winner of the AI race” is not SpaceX
Marc Chaikin - the analyst who called Nvidia before its historic run - says a tech firm labeled 'the unseen wi...
Chaikin Analytics | Sponsoredtc pixel
Where to Put $100 Before Trump's New Tech Law Rolls Out
The Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...
Brownstone Research | Sponsoredtc pixel